MiCo BioMed Co., Ltd. (KOSDAQ: 214610)
South Korea
· Delayed Price · Currency is KRW 1,467.00
+27.00 (1.88%)
Dec 20, 2024, 9:00 AM KST
MiCo BioMed Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -30,008 | -25,774 | -38,893 | -10,575 | -5,776 | -14,632 |
| Depreciation & Amortization | 2,122 | 2,310 | 2,847 | 2,439 | 1,776 | 1,711 |
| Loss (Gain) From Sale of Assets | -3.36 | -2,063 | 192.28 | 0.55 | - | -12.98 |
| Asset Writedown & Restructuring Costs | 739.18 | 739.18 | 1,078 | - | 48.08 | 2,057 |
| Loss (Gain) From Sale of Investments | 580.02 | 577.46 | -5.05 | - | - | - |
| Loss (Gain) on Equity Investments | 1,127 | 3,224 | 7,769 | - | - | - |
| Stock-Based Compensation | 288.5 | - | - | - | 0.04 | -93.63 |
| Provision & Write-off of Bad Debts | 91.66 | 341.4 | 4,643 | 4,218 | 289.46 | 255.25 |
| Other Operating Activities | 11,822 | 12,500 | 8,086 | 1,322 | 9,483 | 1,133 |
| Change in Accounts Receivable | 365.82 | 376.45 | 4,825 | -3,878 | -10,699 | -240.77 |
| Change in Inventory | -1,628 | -1,114 | -2,222 | 500.55 | -14,652 | -500.73 |
| Change in Accounts Payable | 74.31 | 95.75 | 12.9 | -796.42 | 1,069 | 247.23 |
| Change in Other Net Operating Assets | -882.75 | -2,572 | -2,340 | -1,831 | -217.88 | -358.32 |
| Operating Cash Flow | -15,312 | -11,359 | -14,006 | -8,600 | -18,679 | -10,435 |
| Capital Expenditures | -765.47 | -385.41 | -1,625 | -2,841 | -5,761 | -1,338 |
| Sale of Property, Plant & Equipment | 2.83 | 5,110 | 223.2 | -0 | - | 4,500 |
| Cash Acquisitions | -1,622 | -1,622 | - | - | - | - |
| Sale (Purchase) of Intangibles | -16.35 | -295.88 | -35.8 | -289.93 | -261.49 | -215.17 |
| Investment in Securities | -103.72 | -3,010 | -11,450 | -8,876 | -3,239 | 1,054 |
| Other Investing Activities | -47.81 | -24.41 | 245.34 | -7.49 | -50.34 | -468.57 |
| Investing Cash Flow | -3,917 | -8,565 | -12,528 | -12,595 | -9,727 | 2,741 |
| Short-Term Debt Issued | - | 261.08 | - | 4,000 | 11,000 | - |
| Long-Term Debt Issued | - | - | 8,937 | 20,000 | - | 5,000 |
| Total Debt Issued | 2,001 | 261.08 | 8,937 | 24,000 | 11,000 | 5,000 |
| Short-Term Debt Repaid | - | -6,000 | - | - | -8,000 | -300 |
| Long-Term Debt Repaid | - | -16,296 | -666.44 | -938.28 | -956.47 | -3,584 |
| Total Debt Repaid | -29,465 | -22,296 | -666.44 | -938.28 | -8,956 | -3,884 |
| Net Debt Issued (Repaid) | -27,464 | -22,035 | 8,271 | 23,062 | 2,044 | 1,116 |
| Issuance of Common Stock | 45,636 | 45,636 | 56.28 | 671.42 | 37,746 | 10,041 |
| Other Financing Activities | -13.55 | -13.55 | - | - | - | - |
| Financing Cash Flow | 18,158 | 23,587 | 8,327 | 23,733 | 39,789 | 11,157 |
| Foreign Exchange Rate Adjustments | -1.5 | 11.64 | 74.07 | 418.29 | -133.61 | 15.77 |
| Net Cash Flow | -1,073 | 3,676 | -18,133 | 2,956 | 11,250 | 3,479 |
| Free Cash Flow | -16,077 | -11,744 | -15,631 | -11,441 | -24,440 | -11,773 |
| Free Cash Flow Margin | -193.63% | -218.81% | -97.02% | -37.76% | -53.51% | -287.28% |
| Free Cash Flow Per Share | -392.68 | -474.58 | -711.86 | -522.03 | -1396.60 | -827.27 |
| Cash Interest Paid | 445.73 | 360.44 | 646.96 | 46.64 | 253.17 | 503.49 |
| Cash Income Tax Paid | 70.35 | 71.4 | 35.16 | 1.62 | -5.33 | -0.69 |
| Levered Free Cash Flow | -21,159 | -16,397 | 1,230 | -9,991 | -25,843 | - |
| Unlevered Free Cash Flow | -20,059 | -14,413 | 2,746 | -9,632 | -25,409 | - |
| Change in Net Working Capital | 5,491 | 3,552 | -17,760 | 2,153 | 23,330 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.